参考文献/References:
[1] 沈莹姗,何晓铭,赵雄,等.关于“血瘀证是股骨头坏死主要证候”的调查研究[J].中医正骨,2022,34(4):25-29.
[2] 周明旺,刘一飞,吉星,等.基于“瘀去 -新生 -骨合”理论应用活血化瘀法治疗股骨头坏死的思路探讨[J].时珍国医国药,2020,31(12):2988-2990.
[3] 赫龙,高爽,李志刚,等.基于三大组学探讨从“痰、虚、瘀”论治SANFH的可行性[J].时珍国医国药,2022,33(8):1947-1949.
[4] 黄建烽,何海军.从酒伤理论论治酒精性股骨头坏死[J].中医正骨,2022,34(9):69-72.
[5] 李子荣.股骨头坏死:早期诊断与个体化治疗[J].中国矫形外科杂志,2013,21(19):1909-1911.
[6] 李子荣.股骨头坏死成功保髋新理念[J].中医正骨,2018,30(10):1-3.
[7] 杨博,邢涛,张应拴,等.从伏邪理论论治激素性股骨头坏死[J].中医正骨,2023,35(2):54-57.
[8] LI Z,CHENG L,WANG K,et al.Herbal Fufang Xian Ling Gu Bao prevents corticosteroid-induced osteonecrosis of the femoral head—A first multicentre,randomised,double-blind,placebo-controlled clinical trial[J].J Orthop Translat,2018,12:36-44.
[9] 罗月中,李芸,李勇,等.补肾健骨法预防肾病综合征患者激素性股骨头坏死临床研究[J].中医正骨,2011,23(1):3-6.
[10] 何伟.精确诊断前提下股骨头坏死非手术治疗实践[J].临床外科杂志,2017,25(8):580-582.
[11] 何伟.如何把握股骨头坏死患者的保髋治疗时机[J].中国骨与关节杂志,2016,5(2):82-86.
[12] WEI Q,HONG G,YUAN Y,et al.Huo Xue Tong Luo capsule,a vasoactive herbal formula prevents progression of asymptomatic osteonecrosis of femoral head:a prospective study[J].J OrthopTranslat,2019,18: 65-73.
[13] MIN B,SONG K,CHO C,et al.Untreated asymptomatic hips in patients with osteonecrosis of the femoral head[J].Clin Orthop Relat Res,2008,466(5):1087-1092.
[14] HE X,HE M,YANG P,et al.The therapeutic effect of Huo Xue Tong Luo capsules in Association Research Circulation Osseous(ARCO)stage II osteonecrosis of the femoral head:a clinical study with an average follow-up period of 7.95 years[J].Front Pharmacol,2021,12:773758.
[15] 蔡剑.整体观指导下非创伤性股骨头坏死“带塌陷生存”的临床及有限元研究[D].广州:广州中医药大学,2018.
[16] 何伟.科学看待中医药治疗非创伤性股骨头坏死[J].中华关节外科杂志(电子版),2013,7(3):284-286.
[17] ZHAO D,ZHANG F,WANG B,et al.Guidelines for clinical diagnosis and treatment of osteonecrosis of the femoral head in adults(2019 version)[J].J Orthop Translat,2020,21:100-110.
[18] MONT M A,CHERIIAN J J,SIERRA R J,et al.Nontraumatic osteonecrosis of the femoral head:where do we stand today?A ten-year update[J].J Bone Joint Surg Am,2015,97(19):1604-1627.
[19] 刘予豪,周驰,陈雷雷,等.基于股骨头坏死围塌陷期理论的保髋术式总结[J].中国修复重建外科杂志,2017,31(8):1010-1015.
[20] 李泰贤,沈丹青,薛志鹏,等.针刀疗法改善股骨头坏死关节功能的近期疗效观察[J].中国中医骨伤科杂志,2018,26(4):24-28.
[21] 颜炎,李泰贤,傅繁誉,等.针刀刺激肌筋膜疼痛触发点治疗股骨头坏死的疗效观察及作用机制探讨[J].中医正骨,2020,32(11):62-65.
[22] 高在伟,韦伟,韦标方.双柏散治疗非创伤性股骨头坏死的早期观察[J].中国矫形外科杂志,2020,28(21):2005-2007.
[23] MONT M A,ZYWIEEL M G,MARKER D R,et al.The natural history of untreated asymptomatic osteonecrosis of the femoral head:a systematic literature review[J].J Bone Joint Surg Am,2010,92(12):2165-2170.
[24] LIU L,ZHANG Q,SUN W,et al.Corticosteroid-induced osteonecrosis of the femoral head:detection,diagnosis,and treatment in earlier stages[J].Chin Med J(Engl),2017,130(21):2601-2607.
[25] 陈志伟,李泰贤,万晓旭,等.股骨头坏死误诊相关因素研究[J].中国骨伤,2017,30(11):1000-1003.
[26] 魏秋实,何伟,张庆文,等.股骨头坏死中医证型分布规律的文献研究和系统评价[J].中华关节外科杂志(电子版),2013,7(3):369-372.
[27] 李泰贤,陈志伟,王荣田,等.基于文献计量学分析中医药治疗股骨头坏死的研究现状[J].中国中医骨伤科杂志,2017,25(4):41-46.
[28] 许珂,宇文星,宋梦歌,等.股骨头坏死全髋关节置换术患者的人群特征与临床特点分析[J].中医正骨,2020,32(1):51-55.
[29] 中华中医药学会.股骨头坏死中医疗效评价标准(2019年版)[J].中医正骨,2019,31(6):3-6.
[30] 何海军,陈卫衡.将生存质量引入中医药治疗股骨头坏死疗效评价体系的思考[J].中国中医骨伤科杂志,2009,17(4):62-63.
[31] TIAN G,ZHAO C,ZHANG X,et al.Evidence-based traditional Chinese medicine research:two decades of development,its impact,and breakthrough[J].J Evid Based Med,2021,14(1):65-74.
相似文献/References:
[1]陈雷雷,张颖.何伟教授采用中医药疗法治疗股骨头坏死的经验[J].中医正骨,2015,27(10):74.
[2]徐西林,赵永兰,张晓峰,等.活骨注射液髋关节腔灌注对兔股骨头坏死模型
血管内皮生长因子表达的动态影响[J].中医正骨,2015,27(08):1.
XU Xilin,ZHAO Yonglan,ZHANG Xiaofeng,et al.Dynamic effect of intra-articular hip injection of Huogu injection on the expression of vascular endothelial growth factor in rabbit models with femur head necrosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(11):1.
[3]周勇,任菲菲,丰凡翔,等.血管内皮生长因子和骨形态发生蛋白2
在非创伤性股骨头坏死不同区域的表达[J].中医正骨,2015,27(08):7.
ZHOU Yong,REN Feifei,FENG Fanxiang,et al.Expressions of vascular endothelial growth factor and bone morphogenetic protein 2 in different zones of femoral head with non-traumatic osteonecrosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(11):7.
[4]鲍荣华,王国平,夏晓斌,等.钽棒植入治疗非创伤性股骨头坏死的疗效观察[J].中医正骨,2015,27(02):28.
[5]张兵,马凰富,刘波,等.非创伤性股骨头坏死的舌象定量研究[J].中医正骨,2015,27(04):8.
ZHANG Bing,MA Huangfu,LIU Bo,et al.Quantitative study on tongue manifestation of patients with nontraumatic osteonecrosis of femoral head[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(11):8.
[6]李刚,程春生.股骨头坏死血瘀证症状与平乐郭氏正骨方药药物组成
最大频繁关联模式挖掘[J].中医正骨,2015,27(04):21.
LI Gang,CHENG Chunsheng.Maximal frequent association pattern mining for studying the relationship between BLOOD STASIS syndrome in patients with osteonecrosis of femoral head and drug components of Pingle Guo's orthopedics prescription[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(11):21.
[7]李文龙,梅沉成,杜贵强,等.微创减压植骨多孔钽棒植入治疗
ARCOⅡ期非创伤性缺血性股骨头坏死[J].中医正骨,2016,28(02):43.
[8]张磊,金红婷,童培建.骨健口服液早期干预非创伤性股骨头坏死的临床研究[J].中医正骨,2016,28(03):14.
ZHANG Lei,JIN Hongting,TONG Peijian.Clinical study on Gujian Koufuye(骨健口服液)for early intervention of nontraumatic osteonecrosis of femoral head[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(11):14.
[9]鲍荣华,王国平,夏晓斌,等.直接前入路微创全髋关节置换术治疗晚期股骨头坏死[J].中医正骨,2016,28(03):61.
[10]张超,姚晨,沈计荣.微创髓芯减压打压支撑植骨术结合补肾活血汤口服治疗ARCOⅡ、Ⅲ期股骨头坏死的近期疗效观察[J].中医正骨,2016,28(03):20.
ZHANG Chao,YAO Chen,SHEN Jirong.[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(11):20.